October 2, 2025 • 42 mins
In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden and Dr. Nichola Conlon delve into the complexities of aging, focusing on the important role of NAD (Nicotinamide Adenine Dinucleotide) in cellular health and longevity. They discuss how NAD levels decline with age, the implications of this decline, and innovative strategies to boost NAD levels effectively. The conversation also touches on the limitations of IV NAD therapy, the importance of addressing inflammation, and the scientific validation behind the Nuchido Time product. Dr. Conlon shares insights into future research directions and the impact of customer feedback on product development, emphasizing the need for a comprehensive approach to enhancing cellular health.
For Audience
· Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !
· www.nuchido.com/GLADDEN or simply use code GL20 at Checkout on www.nuchido.com for 20% off your first order!
Takeaways
· NAD is crucial for driving cellular repair processes.
· The decline of NAD is linked to aging and inflammation.
· Addressing root causes of NAD decline is essential.
· IV NAD therapy may not effectively increase intracellular NAD levels.
· NAD recycling is a complex process influenced by various enzymes.
· Chronic inflammation can significantly deplete NAD supplies.
· Nuchido Time aims to optimize NAD levels through a comprehensive approach.
· Customer feedback drives ongoing research and product development.
· NAD levels fluctuate throu
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
(00:00):
So NAD actually acts like a fuel to drive many of the repair processes in our cells.
(00:06):
we've got an army of DNA repair enzymes and we've got an army of proteins called sirtuinsthat are monitoring cellular health and switching on things that are protective.
all of these functions in our cell require NAD as a fuel to actually drive this repair.
And this is a really fundamental point that is very misunderstood within the industry isthat we cannot get NAD from our diet.
(00:35):
Our cells actually have a pathway in it that makes and recycles all the NAD that we need.
And this is called the salvage pathway.
NAD is not naturally found at high levels in the blood.
NAD needs to be inside of the cells because that is where all of the pathways that itinteracts with are found.
So yes, an NAD IV will get NAD into the body.
(00:58):
but it's not putting it into the right place.
It's putting it into the blood.
And because NAD is a very large and charged molecule, it does not easily diffuse into ourcells.
(01:38):
Welcome everybody to the Gladden Longevity Podcast.
I'm your host, Dr.
Jeffrey Gladden.
And today we are tackling the big questions in life.
How good can we be?
How do we make 100 a new 30?
How do we live well beyond 120?
How do we live young for a lifetime and how do we develop a 300 year old mind?
And right at the center of those questions are the hallmarks of aging, which are basicallybiological processes that
(02:06):
accelerate aging as they play with each other.
And today I'm going to be talking with Dr.
Nichola Conlon.
We've spoken with her before on the podcast.
She uh has a PhD in biochemistry and is the developer of a product called Nuchido Time.
That's N-U-C-H-I-D-O, Nuchido Time.
(02:29):
We'll talk a little bit about the origin of that name, but it's a
a very comprehensive integrated product to boost NAD levels.
And I think you're going to find this conversation really fascinating.
We talk about NAD, its central role in the hallmarks of aging and anti-aging.
We talk about why it declines, how it declines, how to actually build it.
(02:49):
We talk about IV NAD, what that may be good for and what it's not particularly good for.
ways that it might actually be harmful.
We'll talk about other products, precursors, et cetera.
It's a really good scientific comprehensive conversation around NAD and the ways tooptimize it.
think you're really going to enjoy this podcast.
(03:10):
Welcome everybody to the Gladden on Jeopardy podcast.
I'm your host, Dr.
Jeffrey Gladden.
And today I'm being joined by Dr.
Nichola Conlon.
it's two o'clock in the afternoon here in Dallas and it's 8 PM for her in London orsomeplace in England.
I don't know where you are.
Maybe you're, I don't know where you are in England, but you're someplace Newcastle Okay.
(03:31):
the furthest north you can get basically in England so opposite end to London.
Okay.
Well, I remember back in, I don't know, medical school days, there was a Newcastle ale orsomething that we used to drink.
I don't know if it ever came out of Newcastle, but uh maybe it did.
don't know.
So that's right.
(03:54):
Yeah, that was it.
That was another lifetime ago, but all good.
So you're a Newcastle.
So, know,
It's really a timely topic, always, I think, in the longevity space to be talking aboutNAD.
And, you know, as we sort of expand on the hallmarks of aging, we're now up to about 16that we're looking at.
It's always interesting to see how NAD is kind of at the either
(04:18):
close to the center or at the center of optimizing so many of the hallmarks of aging thesedays, right?
It seems like that keeps expanding.
I don't know if that's your impression as well, but it's fun to see.
You know, and a lot of people always ask me, they always say, why is it out of everythingthat you could have chose to develop or study or really put your effort and focus in a why
(04:41):
did you choose NAD?
And one of the main reasons was because throughout all of the time that I have beeninvolved in this space, you know, really over well over a decade now, NAD has always kept
coming back, as you mentioned, is kind of this molecule
that seems to be at the center of a lot of, if not all of the hallmarks of aging.
(05:04):
There's more and more evidence every day that seems to be appearing that is linking adepletion in NAD with driving the hallmarks of aging or when you actually replenish NAD
with actually improving multiple hallmarks of aging.
So I think even now,
it's pretty safe to say that it is one of the only molecules that seems to have thisreally pleiotropic effect where it's actually impacting multiple different things in one
(05:33):
go.
And as we know, that's really important because all of the hallmarks of aging are notstandalone processes.
So, although as scientists, we like to kind of group them into these very neat boxes.
m They're actually all linked and they're all influencing one another and you're nevergoing to get a real impact if you only target one of them.
(05:56):
So I think that's what's really interesting about NAD and certainly the research thatcontinues to come out in this area.
Yeah, I think that's right.
think for the audience, way that I think it's easy to understand this is that thesehallmarks of aging, which are essentially biological processes that sort of degrade with
aging, but then also because of their degradation, accelerate the rate of aging, theyactually play with each other.
(06:23):
And so it's kind of like a tornado almost kind of spinning up, right?
So when mitochondria don't work, then
You don't have enough ATP, you can't repair your DNA.
When DNA is not repaired, your telomeres get short, blah, blah, blah, blah, blah.
And it keeps sort of playing off each other.
it becomes a complex part of the complexity of reversing aging is actually how do you stopa tornado, right?
(06:46):
When, when it's feeding off of itself and feeding off of all the other hallmarks.
And so when you have a
There are a few things that will come in there.
NAD is one.
A couple other things that come to mind.
Spermidine actually has an impact around most of the hallmarks as well.
So does fasting, like a five day fast, mimicking diet can have an impact on most of thehallmarks of aging.
(07:07):
So it's interesting to look at that.
And then also when you look at really very novel age reversal,
strategies like epigenetic reprogramming, like the David Sinclair paper that was publishedin July of 23, were using a chemical cocktail.
They were able to reprogram epigenetic age, of mimicking the Yamanaka factors, which is,you know, kind of a cellular reprogramming.
(07:33):
You know, one of the things that happens in those more youthful cells is they're able toproduce more NAD and recycle more NAD and use more NAD, right?
So it's really, it's all linked together.
So that being said, know, one of the things that impressed me about your product, NeuchitoTime, was really how well thought it out it was.
(07:54):
You know, how well thought out.
It's not just, take some NMN or some nicotinamide riboside or even some niacin orsomething and just load that into your system.
There's a much more sophisticated thought process there and maybe you can share that withthe audience.
Yeah, absolutely.
And I think, you know, as you've just said, when we're looking at anything in biology,especially in aging, it's all very complex and there's never just one thing at play.
(08:20):
And
what was always interesting to me was how complex the NAD system is in our cells.
You know, often people just think, oh, it's just this one molecule.
It's important.
It declines.
Let's just top it up.
And that's the end of it.
But actually what we know is that there are multiple processes going on in our cells thatare not only using NAD, some of them are recycling it, some of them are actually depleting
(08:47):
it, some of them are making
it, some of them are recycling.
There's all sorts of things going on.
And for a long time as scientists, we knew that NAD fundamentally declines as we getolder.
This is observed in...
all studies that have been done, it's observed in all species that it's been studied in.
So it seems to be a kind of universal decline that we do see with age.
(09:12):
But what was never really understood was exactly why it is declining.
And usually if something has declined in the body, there is a root cause to the problem.
So for a long time, a lot of the focus was not on why it's declined and how we fix theroot cause.
but on the fact that let's just top NAD levels up in any way that we can, whether that'sby using pure NAD in an IV or an injection, or using things like NAD precursors, which are
(09:43):
probably the most famous way to boost NAD, things like NR, nicotinamide riboside, or NMN,which is nicotinamide mononucleotides.
And what these molecules are, which have been used for many, many years now,
or effectively precursors, so like the raw material that your body uses to make NAD.
So the idea behind these products is that if NAD is declined in the body, let's just givethe body more of the raw material and hope that it converts it into NAD.
(10:13):
And which seems very simple, but actually when you start looking deeper at the sciencebehind NAD and more importantly, the more recent research that is coming out, which now
explains why NAD is declining, these products don't really make as much sense anymore.
And to kind of go into that in a little bit more detail, what we, now really know is thatthere are two major root causes of the decline in NAD.
(10:40):
The first one.
is that as we get older, our cells have more damage and they have a higher demand for NAD.
So NAD actually acts like a fuel to drive many of the repair processes in our cells.
So, you know, we've got an army of DNA repair enzymes and we've got an army of proteinscalled sirtuins that are monitoring cellular health and switching on things that are
(11:07):
protective.
all of these functions in our cell require NAD as a fuel to actually drive this repair.
So as we get older, our cells have been around longer, they've got more damage, they'vegot more inflammation, and ultimately they need more repair.
So we start to see an increase in the demand for NAD as we get older.
(11:28):
So that's one reason.
And then right at the same time, what we see is that our capacity to actually make NADalso declines.
And this is a really fundamental point that is very misunderstood within the industry isthat we cannot get NAD from our diet.
(11:49):
Our cells actually have a pathway in it that makes and recycles all the NAD that we need.
And this is called the salvage pathway.
And a key problem that we have when we get older is one of the main enzymes in thissalvage pathway declines with
age.
So we end up in a situation where not only has that demand gone up, but also ourselvesability to make and recycle NAD has also gone down.
(12:14):
So you end up with this perfect storm of right when demands increased, production hasreduced and you get a massive depletion.
And what we wanted to do is kind of go, okay, know, precursors can get you part of theway.
You know, we do know that they do get converted into NAD and we do see a small NAD boost.
but you need to actually fix the root cause of the problem if you want a more sustainablemethod to actually increase NAD levels.
(12:41):
And that is exactly what we developed, a product that actually fixes these root causes ofthe problem.
Yeah, and I think that's right.
So it's really a wheel if you're trying to visualize this of NAD precursors becoming NADbeing used up and then being recycled through this enzyme.
And it's kind of like if your recycling mechanism goes down and your demand goes up, thenyou can see you're going to end up in a shortage.
(13:09):
And there's another piece to this equation that I know New Cheeto Time addresses, which isCD38.
portion of this.
Yeah, absolutely.
So what we know is that CD38 is a very important piece of the puzzle, as you mentioned.
(13:32):
And what CD38 is, is it's a pro-inflammatory enzyme.
So essentially when our inflammatory response is switched on, CD38 is part of the cascadethat actually drives the inflammatory response.
So every time we have an inflammatory reaction, CD38 gets turned up.
Now what we know is that as we get older, sometimes that inflammatory response is notquite turned off.
(13:59):
fully.
So as we go throughout life, we kind of get small amounts of this inflammation that'sstill switched on that builds up in our body and it acts almost like small, like a
smoldering fire.
And we know it's incredibly damaging to ourselves.
And part of this is actually linked to higher CD38 expression.
So you will see in an older person that they will have more CD38.
(14:24):
And the key link here with NAD is that
NAD is actually one of the drivers of CD38.
So when CD38 is switched on, it is using up a huge amount of our NAD supplies.
So this is the link between the fact that high levels of chronic inflammation as we getolder are actually further driving down our NAD supplies.
(14:47):
And this is something that actually has a profound impact on our NAD levels.
You know, some of the studies have shown that even by addressing this problem, you canincrease NAD levels by 50 % just by addressing this wastage problem, shall we say.
The other issue is that, and again, something that's not really spoke about much is whenyou are boosting NAD, what you need to make sure is that the NAD that you are creating is
(15:17):
actually going towards beneficial processes.
So you want the NAD to be going to DNA repair enzymes.
You want it to go in to be activating the sirtuins.
What you absolutely do not want happening is it to be activating CD38.
And this is a real risk because actually CD38 has what is known as a high affinity forNAD.
(15:41):
And essentially what that means is that if NAD is available in the cell,
The CD38 enzyme will grab it and use it before the sirtuins can use it, before the DNArepair enzymes can use it.
So you really do need to make sure that you inhibit CD38 as part of your NAD boostingstrategy to make sure the NAD is going to beneficial processes.
(16:05):
Sounds like the Russian economy, right?
You've got corruption that's basically pulling off the NAD.
Then you've got a mechanism for recycling that's declining, right?
The manufacturing is declining.
Then you've got an increasing need because of ongoing damage.
So this is how you set up collapse, right?
(16:25):
This would be how you would set up economic collapse.
If you're thinking about it in economic terms for the cell.
It's almost economic collapse for the cell if NAD is the currency here, right?
it becomes a, it's a huge mess.
And you know, one thing is then driving the other thing to become more worse.
And you end up in this cycle, which is why it is so important to actually address theseroot causes rather than just trying to ignore all the problems and, know, chuck in some,
(16:55):
guess, chuck in some new currency or chuck in some new raw material.
Yeah.
to print money to overcome the problem, right?
So staying on the economic bandwagon here.
You know, the interesting thing is if you're just throwing NR, NMN, or even NISIN into themix alone, is now you're sort of stacking up bricks in front of a machine that's
(17:17):
distracted and things are going haywire anyway, and they can't really make good use of it,right?
So one of the things that you've done, I think,
both wisely, interestingly, and expertly is to actually navigate all the elements of thesystem to where you're providing not only the precursors, but you're also accelerating the
(17:37):
recycling at the same time you're blocking the CD38, right?
So it becomes a more comprehensive approach.
Do want to talk through a little bit about the studies that you've done that have shownthe impact of the synergy and maybe compare that to people that are
thinking about IV and AD versus kind of what you're doing.
That might be interesting.
(17:58):
Yeah.
So, I mean, essentially what we're trying to do is make the cell act like it did when itwas young and when NAD production was kind of in full swing, because we know in youthful,
healthy cells, our body makes and recycles all the NAD it needs in this salvage pathway.
Literally as NAD is used up, it gets broken down into a precursor called nicotinamide.
(18:21):
Then this nicotinamide gets scooped straight back up.
and recycled back into fresh NAD again.
And really it's a very clever way of the cell not relying on a critical molecule from theoutside, but it also means that as NAD demand goes up, because NAD is being used and
(18:42):
broken down in the precursor, it also means there's more precursor available to then meetthe demand in the cell.
So it's a very clever system that is set up that does work really well.
and when it's working efficiently.
But the key problem here, especially in this pathway, is the rate limit and enzyme NAMPT.
And basically, the less NAMPT you have, the less of this recycling process happens.
(19:07):
And that is the key enzyme that we see actually decline with age.
So I think what you see is if you don't address this problem and you ignore
this pathway and you just take NMN or you just take NR, what happens is some of that willgo into the system.
(19:28):
It will get converted into NAD, but then it's used once and it's essentially broken down.
And when it's broken down, it gets converted into one of its precursors, which isnicotinamide.
But if this salvage pathway, this enzyme is not working to recycle this nicotinamide,
what we see happen is it actually starts to build up in the cell and it gets to the pointwhere the cells like, actually this is too much, we need to get rid of it.
(19:55):
So instead of this precursor being recycled into fresh NAD, the cell actually methylatesit and excretes it out of the cell.
So again, what you start to see is you start to see an increase in another enzyme, whichis called NNMT, which is a methylated enzyme.
which becomes over expressed as the cell is struggling to actually get rid of this excessnicotinamide.
(20:20):
And this is a problem because it can cause methyl donor depletion because your methylgroups should not be getting used for this process.
They should be getting used for much more important things like DNA repair, et cetera, etcetera.
But they start getting used for this process.
And this becomes even more of a problem if you are taking huge amounts of precursors,because suddenly you're getting piles and piles of these precursors in the cell that the
(20:49):
cell simply can't deal with.
And we do see in some of the human clinical studies that have been done on things like NRand NMN that we see an increase.
in methyl nicotinamide.
So basically as they increase the dose of the precursor, it increases NAD to a certainpoint, but then it doesn't matter how much they increase the precursor, the level of NAD
(21:13):
plateaus.
And that is because the cell can't keep converting it into NAD.
And then what you see is the levels of this methyl nicotinamide, this excretory productkeeps going up and up and up and up.
which again shows us in clear solid evidence, this is not a theory, this is in a humanclinical trial, that the system is becoming overwhelmed and it's starting to have to
(21:37):
change other elements of its physiology to deal with this problem to maintain homeostasis.
So, you know, that is a key, a key part of why we wanted to design something different.
You mentioned very briefly m NAD IVs and also probably NAD injections that have becomevery popular.
(21:57):
mean, a lot of issues around not only the theory behind this, but now some of the clinicalevidence coming out.
Because a lot of people kind of think, well, you know, if NAD is declined, can we give thebody pure NAD and will it just go into the cell and get to where it's needed?
But what an NAD IV or an injection does is it actually puts NAD into our blood.
(22:21):
And NAD is not naturally found at high levels in the blood.
NAD needs to be inside of the cells because that is where all of the pathways that itinteracts with are found.
So what we see and what I've spoke about for a long time now is the fact that yes, an NADIV will get NAD into the body.
but it's not putting it into the right place.
(22:43):
It's putting it into the blood.
And because NAD is a very large and charged molecule, it does not easily diffuse into our
cells.
It struggles to cross the cell membrane and it certainly needs a very special transport, aprotein or carrier to get it in.
And the majority of our cells simply don't have this pathway to get it in.
(23:04):
So what we see is that the NAD is going into a person's blood and it's effectively gettingstuck there.
Now there have been two clinical trials, which I always find astounding that there arestill only two clinical trials looking at what happens to the NAD considering the amount
of clinics that are actually doing NAD IVs.
And one of the clinical studies showed that the NAD is rapidly degraded into precursors.
(23:30):
And then some of these precursors are then taken up.
in which case you've got exactly the same problem as just taking an oral precursor.
The other paper, more alarmingly, actually showed that not only did IV NAD not increaseintracellular NAD, but it triggered an inflammatory reaction.
(23:51):
So they saw increased levels of IL in the leukins in the bodies.
And again, this is worrying because obviously, like we...
We don't want to take NAD to increase inflammation.
But again, you know, looking at this from a purely physiological theoretical point, NAD isnot found in huge levels in the blood.
(24:13):
So if you're suddenly putting a huge dose of NAD into the blood, that's usually only foundinside the cells, the body's thinking, my goodness, what's happened?
Has there been a trauma?
You know, has there been something that's caused the cells to release a lot of theircontents?
and it perceives it as a trauma or a threat.
(24:33):
So it initiates an inflammatory reaction to deal with this perceived trauma.
So again, I'm really happy to see these studies now coming out because it supportssomething that I've kind of been saying theoretically for a long time.
Yeah, it's really interesting.
We've never been huge fans of IV NAD.
I know there are some particular indications where it seems to be useful, like an acutealcohol withdrawal or opioid withdrawal or situations like that.
(25:01):
It can actually be have a very salutary effect.
And yet I think for the kinds of reasons that people are running into a clinic to get anIV of NAD, I think it's actually counterproductive.
um Even though it's well intended, it's counterproductive, right?
That's why I think understanding the biochemistry the way that you do and basicallyarchitecting a system to elevate intracellular NAD levels, the way that you've architected
(25:27):
it becomes really kind of the most intelligent approach.
I will say that in our practice, one of the things that we have also found to be helpfulis
Um, using an ozone sauna to oxidize NADH back to NAD to change the NAD to NADH ratio in afavorable way.
(25:52):
And what we've found is that when you, uh, take something like Neucheto time, um, and you,you load this into your system and then you jump in an ozone sauna.
Oh my gosh.
So like the next three or four days, you can feel like Superman or Wonder Woman, right?
mean, it's just, you really get an amazing boost in NAD.
(26:15):
You can feel the ATP that comes off the mitochondria from it.
if you throw in some, either some D ribose along with some vitamin B2, some riboflavin, Imean, the next thing you know, it's like, my gosh, let's go climb Mount Everest.
So it's been cool.
what?
never heard that combination before, so that's really interesting.
(26:36):
But again, from a scientific standpoint, it makes total sense because we know that NAD isa redox molecule.
And so therefore it naturally flips between two states.
One of them, it's oxidized form, which you see written as NAD plus, and the other it'sreduced form NADH.
And what we know is that as you get older,
(26:58):
the ratio starts to shift more towards NADH and that's not the direction you want it to begoing in.
You want to have a higher ratio of NAD+.
So that's really interesting to use that in combination with the ozone therapy.
Yeah, it seems to work really well.
And we'll take some molecular hydrogen too, actually, just to help kind of mop up, if youwill, some of the uh oxidative stress, the excess oxidative stress you might get from the
(27:27):
ozone.
So anyway, it's something we've kind of biohacked our way into just looking at, you know,what can we do to optimize this, since that's the question we're always asking.
And that seems to be quite honestly, the hot ticket.
In fact, I'm going to no, no pun intended.
think I'm going to do that after this podcast, just cause I got in late last night from aflight that was delayed and I'm feeling like I could use a boost.
(27:51):
So yeah.
Yeah, that sounds like the perfect boost.
And we know things like travel, any jet lag, anything like that is also something thatdepletes NAD, probably because what we haven't...
discussed is, you know, not only does NAD naturally decline with age, but lifestyle isalso a huge thing that impacts our NAD levels, meaning that in some people it will decline
(28:16):
quicker than others.
We know people that travel a lot, people that have circadian disruption, and we seedepleted NAD levels in those people.
So yeah, definitely jump in that, eh in that chamber later and yeah, get those levels backup.
Yeah, very cool.
So, you know, one of the exciting things that I recently discovered on a call that we hadwas the fact that you've been able to kind of refine your packaging, if you will.
(28:46):
In other words, it used to be that the daily dose was about six capsules and now I thinkit's down to three.
Do you want to talk about how you did that without compromising the delivery of theproduct?
I think people would be interested.
when we first developed the product, our aim was to get a product out to market thatactually works and has good science behind it.
(29:07):
my PhD back in the day was actually all surrounding bioavailability of active molecules,of drugs, of nutrients.
So I was always very particular.
and very picky about what formats of different ingredients that we used.
So for example, we've spoken a lot about how we uh target CD38.
(29:31):
Now, the way we target CD38 is through an active ingredient called Apigenin.
We know that Apigenin is a very powerful inhibitor of CD38.
And so we wanted to include this in our product to actually m inhibit it.
And unfortunately, there's a lot of hype about using purified active molecules.
(29:53):
So for example, a lot of the studies on apigenin have used pure apigenin.
They've put it in cell culture.
They've shown that it inhibits CD38, which is great.
But the reality is that in nature, apigenin doesn't exist in a pure form, which means thatyou cannot just take pure apigenin orally, and it will not have the same effect because it
(30:14):
can get damaged in the gut.
So in order to get these active ingredients into the body in stabilized form, often whatyou have to do is use m plant extracts.
So in our formulation, you'll see we use m parsley extract.
And everyone's always like, why on earth?
What is parsley doing in this product?
But we know parsley is a very good source of natural epigenetin.
(30:36):
But that means that you have to use quite a lot of the active ingredients to then actuallybe able to get the effect.
So the result was that when we did our initial clinical trials, the formulation wasn't incapsules.
It was something that you just have as a powder and drink it and it had its effect, but ittasted horrendous.
(30:57):
So that was never going to be acceptable to consumers.
So it had to be encapsulated.
And when it was encapsulated, that's when we realized it's six capsules.
So because we just wanted to get a product out there that worked,
we were much more concerned about having the correct doses and having more capsules thantrying to cut it and have less capsules and, you know, and get it out there.
(31:21):
So that's why when we initially launched, it was six capsules.
But since then, and because we actually launched back in 2019, believe it or not,ingredient science is really advanced.
So some of the ingredients that we use have now become much more purified and extracted.
meaning that we can now use lesser amounts of the raw materials to get the same amount ofactive.
(31:46):
So a key difference, just again as an example of something we've changed, is the alphalipoic acid.
So alpha lipoic acid is a key part of the formulation.
It's one of the ingredients that helps to switch on the NAMPT enzyme, this salvage pathwayenzyme.
Um, but a key problem that we always had was the bulk of this raw material that had to beused to actually get the desired efficacy, in the cells.
(32:14):
And that's because alkaloid proic acid is an incredibly unstable molecule.
So you need to use way over, and to ensure that by the time it's degraded in the body, gotthrough the gut, that there's enough left to have its active, its active role.
Now, when we launched, we used the best product or the best
format that was available but since over the years there have actually become new versionsavailable.
(32:38):
So for example the ALA is now available as an ALA salt and this actually massivelystabilizes the alpha lipoic acid meaning that you can use a huge amount less to actually
get the same active benefit in the body.
So through various tweaks like this, we've been able to actually get the formulation downinto three capsules, which has been a big advantage em for consumers taking it.
(33:06):
You can take all three capsules in one go with food.
And again, because we are very scientifically credible and we want to back everything thatwe're doing, we actually went and did another full clinical trial to prove that it works
just as well.
as the six capsule.
So we did a head-to-head clinical trial to actually show that it still has the samebenefit as well.
(33:29):
Because what we haven't mentioned is we have done a double-blind placebo controlledclinical study on the product, which certainly for supplements is pretty rare.
And also in the NAD space is pretty rare because there's a lot of products out there thatmake a lot of claims, but don't actually have any research in humans to back it up.
Yeah, no, it's really great.
(33:51):
It's nice to see how you continue to kind of think through the product and find ways tooptimize it, not only for efficacy, but also just the convenience of taking fewer
capsules, right?
I mean, there is such a thing as capsule fatigue of people who are taking a lot ofdifferent supplements.
So that's super helpful.
Yeah.
goal with Nishido has always been how do we get this science out to people and make it asuser friendly as possible, whether that's user friendly in terms of the education and
(34:21):
people's understanding of it, or it's user friendly in terms of the price and cost and,you know, acceptability of people actually being able to take it.
Because, you know, as well as I, that these things can actually have a real significantimpact on people's life.
and when they improve their cellular health on the inside, it really does have an impact.
(34:42):
Tell me about the name Neuchito.
Where did that come from?
It sounds like it rhymes with Dorito, but it's...
So, so, no, it's, it's, it's a made up word, but it does have some basis to it in thelongevity field.
because you, will have, you will know of the blue zones.
So the places in the world where, you know, people seem to live to a great age and inrelatively good health compared to a lot of countries in the world.
(35:08):
And one of the famous blue zones is Okinawa in Japan.
and they have a saying, which is Nishi Kusui, which is food.
is path to long life.
So we sort of stole the Nushi bit and put the dough on his way.
So it loosely kind of has a meaning, but also it's very much made up because it's veryhard to get a name that you can trademark.
(35:28):
Right.
That's true.
That's true.
It's hard to get a name you can trademark.
Cool.
All right.
Well, that's good.
I didn't realize it was connected to Okinawa.
So good to know.
All right.
Cool.
sense behind it a little bit anyway.
So what's on the drawing board for you guys?
Anything, any other things you've got up your sleeve there in terms that you're working onor perfecting this?
(35:49):
I mean, in terms of this product, we are always trying to do further clinical research onit.
And a lot of this is based on customer feedback.
So more and more, we get all sorts of customer feedback and some things begin to trendwhere we're hearing it time and time again.
And as a scientific company, we don't like to rely on anecdotal data or, know, customerreviews or quotes.
(36:15):
We like to get some solid evidence behind it.
So we continue to do smaller studies looking at some of this feedback that we're getting.
So like a key one that we've done was a sleep study because we were getting so manycustomers saying that they were noticing an improvement to their sleep quality.
A lot of our customers have the aura rings or the Woot bands.
(36:35):
They were noticing improved deep sleep.
They were noticing better HRV.
So we wanted to do a study to actually measure this.
So we did do a three-month sleep study.
Now granted it was a questionnaire-based study, it was using something called thePittsburgh Sleep Quality Analysis, but we did see in all of the 30 participants that 26 of
(36:56):
them all saw a significant improvement in sleep quality and the four that didn't just sawnothing change.
So that kind of confirms that something is going on here to improve sleep.
Again, theoretically, it makes perfect sense.
NAD is very important in regulating circadian rhythm.
And so we know that it does have a role in sleep.
(37:17):
And so from this, we then want to go on and do a further sleep study, which is then usingtracking devices to actually really measure this.
And the other thing we're really interested in is studies surrounding
What happens if you improve cellular health on the inside?
Does it have visible and noticeable changes to things like skin quality on the outside?
(37:37):
And we've done some studies, again, looking at skin quality with m special skin analyzercameras that take pictures of different layers of the skin.
They take pictures of the pigmentation, rosacea, redness.
And we've saw improvements to these parameters as well.
And the other area that we're really interested in is menopause, because a huge number ofthe positive feedback from customers that we get is actually perimenopausal and menopausal
(38:03):
women that say how much of a real difference it's made to their brain fog and also energylevels.
So we're looking to actually set up a study with specifically with this category ofpeople.
and to get some data behind that.
So that's kind of where we're focused on this product.
But in the, you know, in the backend, again, we're actively researching company.
(38:28):
I have PhD students that collaborate with universities.
We do a lot of research and a big area of interest for us is senescence.
And that's got some really exciting projects that's ongoing and that I can't say too muchabout now, but.
It's kind of all taken away in the background.
And as you know, Senescence and NAD also has a very powerful link between them.
(38:52):
That's right.
No, that's exciting.
That's very cool.
I had not heard about brain fog for perimenopausal women or postmenopausal.
know, men go through andropause also.
I wonder if it would be helpful to them as well.
It might.
we do have men, you know, that report, especially in that sort of period of life, asignificant improvement, especially in things like brain fog, because men do get that as
(39:15):
well.
It's usually a bit more gradual onset as opposed to women that really notice it becauseit's usually quite drastic.
And also, if you look at the hormones in women, things like estrogen are, when they drop,they're incredibly...
pro-inflammatory because estrogen normally keeps inflammation at bay.
So when estrogen suddenly plummets, you get an increase in inflammation and then you getit is right at the time when NAD is massively declining as well.
(39:41):
So you almost get this perfect storm.
So even if you're not addressing the hormones and you're only addressing NAD, you do see asignificant improvement.
Nice.
Yeah, no, that's really cool.
So with the sleep, are you finding that people are taking their Nuchido time at bedtime toget the best results with sleep or just when they take it?
to take it in the morning or as close to the early in the day as you can take it with yourfirst meal of the day.
(40:07):
And that's just because, um, any of the actually naturally fluctuates throughout the day.
It's not a constant.
Um, and it's these fluctuating levels of NAD that actually helped to regulate switchingthis circadian cycle on and off.
Um, and it's better to, it's kind it's not the time at which you take it.
It's just the fact that your whole NAD cycle.
(40:27):
m is functioning better.
So it has that influence over the circadian rhythm as opposed to when the whole NAD cycleis all disrupted, it doesn't have that strong influence as it should to switching on and
off those circadian transcription factors.
Yeah, nice.
Awesome.
Well, lovely to catch up with you again.
(40:48):
Really nice progress that you've made.
And really congratulations on being able to condense the formulation to three capsules.
We just got a hold of some of those in the office here, I don't know, a few weeks ago.
And people are enjoying having to take fewer capsules.
That's been great.
So.
no, I bet.
No, thanks.
been really nice to catch up as well.
It's always good to have a really detailed science chat with someone I appreciate.
So NAD actually acts like a fuel to drive many of the repair processes in our cells.
(00:06):
we've got an army of DNA repair enzymes and we've got an army of proteins called sirtuinsthat are monitoring cellular health and switching on things that are protective.
all of these functions in our cell require NAD as a fuel to actually drive this repair.
And this is a really fundamental point that is very misunderstood within the industry isthat we cannot get NAD from our diet.
(00:35):
Our cells actually have a pathway in it that makes and recycles all the NAD that we need.
And this is called the salvage pathway.
NAD is not naturally found at high levels in the blood.
NAD needs to be inside of the cells because that is where all of the pathways that itinteracts with are found.
So yes, an NAD IV will get NAD into the body.
(00:58):
but it's not putting it into the right place.
It's putting it into the blood.
And because NAD is a very large and charged molecule, it does not easily diffuse into ourcells.
(01:38):
Welcome everybody to the Gladden Longevity Podcast.
I'm your host, Dr.
Jeffrey Gladden.
And today we are tackling the big questions in life.
How good can we be?
How do we make 100 a new 30?
How do we live well beyond 120?
How do we live young for a lifetime and how do we develop a 300 year old mind?
And right at the center of those questions are the hallmarks of aging, which are basicallybiological processes that
(02:06):
accelerate aging as they play with each other.
And today I'm going to be talking with Dr.
Nichola Conlon.
We've spoken with her before on the podcast.
She uh has a PhD in biochemistry and is the developer of a product called Nuchido Time.
That's N-U-C-H-I-D-O, Nuchido Time.
(02:29):
We'll talk a little bit about the origin of that name, but it's a
a very comprehensive integrated product to boost NAD levels.
And I think you're going to find this conversation really fascinating.
We talk about NAD, its central role in the hallmarks of aging and anti-aging.
We talk about why it declines, how it declines, how to actually build it.
(02:49):
We talk about IV NAD, what that may be good for and what it's not particularly good for.
ways that it might actually be harmful.
We'll talk about other products, precursors, et cetera.
It's a really good scientific comprehensive conversation around NAD and the ways tooptimize it.
think you're really going to enjoy this podcast.
(03:10):
Welcome everybody to the Gladden on Jeopardy podcast.
I'm your host, Dr.
Jeffrey Gladden.
And today I'm being joined by Dr.
Nichola Conlon.
it's two o'clock in the afternoon here in Dallas and it's 8 PM for her in London orsomeplace in England.
I don't know where you are.
Maybe you're, I don't know where you are in England, but you're someplace Newcastle Okay.
(03:31):
the furthest north you can get basically in England so opposite end to London.
Okay.
Well, I remember back in, I don't know, medical school days, there was a Newcastle ale orsomething that we used to drink.
I don't know if it ever came out of Newcastle, but uh maybe it did.
don't know.
So that's right.
(03:54):
Yeah, that was it.
That was another lifetime ago, but all good.
So you're a Newcastle.
So, know,
It's really a timely topic, always, I think, in the longevity space to be talking aboutNAD.
And, you know, as we sort of expand on the hallmarks of aging, we're now up to about 16that we're looking at.
It's always interesting to see how NAD is kind of at the either
(04:18):
close to the center or at the center of optimizing so many of the hallmarks of aging thesedays, right?
It seems like that keeps expanding.
I don't know if that's your impression as well, but it's fun to see.
You know, and a lot of people always ask me, they always say, why is it out of everythingthat you could have chose to develop or study or really put your effort and focus in a why
(04:41):
did you choose NAD?
And one of the main reasons was because throughout all of the time that I have beeninvolved in this space, you know, really over well over a decade now, NAD has always kept
coming back, as you mentioned, is kind of this molecule
that seems to be at the center of a lot of, if not all of the hallmarks of aging.
(05:04):
There's more and more evidence every day that seems to be appearing that is linking adepletion in NAD with driving the hallmarks of aging or when you actually replenish NAD
with actually improving multiple hallmarks of aging.
So I think even now,
it's pretty safe to say that it is one of the only molecules that seems to have thisreally pleiotropic effect where it's actually impacting multiple different things in one
(05:33):
go.
And as we know, that's really important because all of the hallmarks of aging are notstandalone processes.
So, although as scientists, we like to kind of group them into these very neat boxes.
m They're actually all linked and they're all influencing one another and you're nevergoing to get a real impact if you only target one of them.
(05:56):
So I think that's what's really interesting about NAD and certainly the research thatcontinues to come out in this area.
Yeah, I think that's right.
think for the audience, way that I think it's easy to understand this is that thesehallmarks of aging, which are essentially biological processes that sort of degrade with
aging, but then also because of their degradation, accelerate the rate of aging, theyactually play with each other.
(06:23):
And so it's kind of like a tornado almost kind of spinning up, right?
So when mitochondria don't work, then
You don't have enough ATP, you can't repair your DNA.
When DNA is not repaired, your telomeres get short, blah, blah, blah, blah, blah.
And it keeps sort of playing off each other.
it becomes a complex part of the complexity of reversing aging is actually how do you stopa tornado, right?
(06:46):
When, when it's feeding off of itself and feeding off of all the other hallmarks.
And so when you have a
There are a few things that will come in there.
NAD is one.
A couple other things that come to mind.
Spermidine actually has an impact around most of the hallmarks as well.
So does fasting, like a five day fast, mimicking diet can have an impact on most of thehallmarks of aging.
(07:07):
So it's interesting to look at that.
And then also when you look at really very novel age reversal,
strategies like epigenetic reprogramming, like the David Sinclair paper that was publishedin July of 23, were using a chemical cocktail.
They were able to reprogram epigenetic age, of mimicking the Yamanaka factors, which is,you know, kind of a cellular reprogramming.
(07:33):
You know, one of the things that happens in those more youthful cells is they're able toproduce more NAD and recycle more NAD and use more NAD, right?
So it's really, it's all linked together.
So that being said, know, one of the things that impressed me about your product, NeuchitoTime, was really how well thought it out it was.
(07:54):
You know, how well thought out.
It's not just, take some NMN or some nicotinamide riboside or even some niacin orsomething and just load that into your system.
There's a much more sophisticated thought process there and maybe you can share that withthe audience.
Yeah, absolutely.
And I think, you know, as you've just said, when we're looking at anything in biology,especially in aging, it's all very complex and there's never just one thing at play.
(08:20):
And
what was always interesting to me was how complex the NAD system is in our cells.
You know, often people just think, oh, it's just this one molecule.
It's important.
It declines.
Let's just top it up.
And that's the end of it.
But actually what we know is that there are multiple processes going on in our cells thatare not only using NAD, some of them are recycling it, some of them are actually depleting
(08:47):
it, some of them are making
it, some of them are recycling.
There's all sorts of things going on.
And for a long time as scientists, we knew that NAD fundamentally declines as we getolder.
This is observed in...
all studies that have been done, it's observed in all species that it's been studied in.
So it seems to be a kind of universal decline that we do see with age.
(09:12):
But what was never really understood was exactly why it is declining.
And usually if something has declined in the body, there is a root cause to the problem.
So for a long time, a lot of the focus was not on why it's declined and how we fix theroot cause.
but on the fact that let's just top NAD levels up in any way that we can, whether that'sby using pure NAD in an IV or an injection, or using things like NAD precursors, which are
(09:43):
probably the most famous way to boost NAD, things like NR, nicotinamide riboside, or NMN,which is nicotinamide mononucleotides.
And what these molecules are, which have been used for many, many years now,
or effectively precursors, so like the raw material that your body uses to make NAD.
So the idea behind these products is that if NAD is declined in the body, let's just givethe body more of the raw material and hope that it converts it into NAD.
(10:13):
And which seems very simple, but actually when you start looking deeper at the sciencebehind NAD and more importantly, the more recent research that is coming out, which now
explains why NAD is declining, these products don't really make as much sense anymore.
And to kind of go into that in a little bit more detail, what we, now really know is thatthere are two major root causes of the decline in NAD.
(10:40):
The first one.
is that as we get older, our cells have more damage and they have a higher demand for NAD.
So NAD actually acts like a fuel to drive many of the repair processes in our cells.
So, you know, we've got an army of DNA repair enzymes and we've got an army of proteinscalled sirtuins that are monitoring cellular health and switching on things that are
(11:07):
protective.
all of these functions in our cell require NAD as a fuel to actually drive this repair.
So as we get older, our cells have been around longer, they've got more damage, they'vegot more inflammation, and ultimately they need more repair.
So we start to see an increase in the demand for NAD as we get older.
(11:28):
So that's one reason.
And then right at the same time, what we see is that our capacity to actually make NADalso declines.
And this is a really fundamental point that is very misunderstood within the industry isthat we cannot get NAD from our diet.
(11:49):
Our cells actually have a pathway in it that makes and recycles all the NAD that we need.
And this is called the salvage pathway.
And a key problem that we have when we get older is one of the main enzymes in thissalvage pathway declines with
age.
So we end up in a situation where not only has that demand gone up, but also ourselvesability to make and recycle NAD has also gone down.
(12:14):
So you end up with this perfect storm of right when demands increased, production hasreduced and you get a massive depletion.
And what we wanted to do is kind of go, okay, know, precursors can get you part of theway.
You know, we do know that they do get converted into NAD and we do see a small NAD boost.
but you need to actually fix the root cause of the problem if you want a more sustainablemethod to actually increase NAD levels.
(12:41):
And that is exactly what we developed, a product that actually fixes these root causes ofthe problem.
Yeah, and I think that's right.
So it's really a wheel if you're trying to visualize this of NAD precursors becoming NADbeing used up and then being recycled through this enzyme.
And it's kind of like if your recycling mechanism goes down and your demand goes up, thenyou can see you're going to end up in a shortage.
(13:09):
And there's another piece to this equation that I know New Cheeto Time addresses, which isCD38.
portion of this.
Yeah, absolutely.
So what we know is that CD38 is a very important piece of the puzzle, as you mentioned.
(13:32):
And what CD38 is, is it's a pro-inflammatory enzyme.
So essentially when our inflammatory response is switched on, CD38 is part of the cascadethat actually drives the inflammatory response.
So every time we have an inflammatory reaction, CD38 gets turned up.
Now what we know is that as we get older, sometimes that inflammatory response is notquite turned off.
(13:59):
fully.
So as we go throughout life, we kind of get small amounts of this inflammation that'sstill switched on that builds up in our body and it acts almost like small, like a
smoldering fire.
And we know it's incredibly damaging to ourselves.
And part of this is actually linked to higher CD38 expression.
So you will see in an older person that they will have more CD38.
(14:24):
And the key link here with NAD is that
NAD is actually one of the drivers of CD38.
So when CD38 is switched on, it is using up a huge amount of our NAD supplies.
So this is the link between the fact that high levels of chronic inflammation as we getolder are actually further driving down our NAD supplies.
(14:47):
And this is something that actually has a profound impact on our NAD levels.
You know, some of the studies have shown that even by addressing this problem, you canincrease NAD levels by 50 % just by addressing this wastage problem, shall we say.
The other issue is that, and again, something that's not really spoke about much is whenyou are boosting NAD, what you need to make sure is that the NAD that you are creating is
(15:17):
actually going towards beneficial processes.
So you want the NAD to be going to DNA repair enzymes.
You want it to go in to be activating the sirtuins.
What you absolutely do not want happening is it to be activating CD38.
And this is a real risk because actually CD38 has what is known as a high affinity forNAD.
(15:41):
And essentially what that means is that if NAD is available in the cell,
The CD38 enzyme will grab it and use it before the sirtuins can use it, before the DNArepair enzymes can use it.
So you really do need to make sure that you inhibit CD38 as part of your NAD boostingstrategy to make sure the NAD is going to beneficial processes.
(16:05):
Sounds like the Russian economy, right?
You've got corruption that's basically pulling off the NAD.
Then you've got a mechanism for recycling that's declining, right?
The manufacturing is declining.
Then you've got an increasing need because of ongoing damage.
So this is how you set up collapse, right?
(16:25):
This would be how you would set up economic collapse.
If you're thinking about it in economic terms for the cell.
It's almost economic collapse for the cell if NAD is the currency here, right?
it becomes a, it's a huge mess.
And you know, one thing is then driving the other thing to become more worse.
And you end up in this cycle, which is why it is so important to actually address theseroot causes rather than just trying to ignore all the problems and, know, chuck in some,
(16:55):
guess, chuck in some new currency or chuck in some new raw material.
Yeah.
to print money to overcome the problem, right?
So staying on the economic bandwagon here.
You know, the interesting thing is if you're just throwing NR, NMN, or even NISIN into themix alone, is now you're sort of stacking up bricks in front of a machine that's
(17:17):
distracted and things are going haywire anyway, and they can't really make good use of it,right?
So one of the things that you've done, I think,
both wisely, interestingly, and expertly is to actually navigate all the elements of thesystem to where you're providing not only the precursors, but you're also accelerating the
(17:37):
recycling at the same time you're blocking the CD38, right?
So it becomes a more comprehensive approach.
Do want to talk through a little bit about the studies that you've done that have shownthe impact of the synergy and maybe compare that to people that are
thinking about IV and AD versus kind of what you're doing.
That might be interesting.
(17:58):
Yeah.
So, I mean, essentially what we're trying to do is make the cell act like it did when itwas young and when NAD production was kind of in full swing, because we know in youthful,
healthy cells, our body makes and recycles all the NAD it needs in this salvage pathway.
Literally as NAD is used up, it gets broken down into a precursor called nicotinamide.
(18:21):
Then this nicotinamide gets scooped straight back up.
and recycled back into fresh NAD again.
And really it's a very clever way of the cell not relying on a critical molecule from theoutside, but it also means that as NAD demand goes up, because NAD is being used and
(18:42):
broken down in the precursor, it also means there's more precursor available to then meetthe demand in the cell.
So it's a very clever system that is set up that does work really well.
and when it's working efficiently.
But the key problem here, especially in this pathway, is the rate limit and enzyme NAMPT.
And basically, the less NAMPT you have, the less of this recycling process happens.
(19:07):
And that is the key enzyme that we see actually decline with age.
So I think what you see is if you don't address this problem and you ignore
this pathway and you just take NMN or you just take NR, what happens is some of that willgo into the system.
(19:28):
It will get converted into NAD, but then it's used once and it's essentially broken down.
And when it's broken down, it gets converted into one of its precursors, which isnicotinamide.
But if this salvage pathway, this enzyme is not working to recycle this nicotinamide,
what we see happen is it actually starts to build up in the cell and it gets to the pointwhere the cells like, actually this is too much, we need to get rid of it.
(19:55):
So instead of this precursor being recycled into fresh NAD, the cell actually methylatesit and excretes it out of the cell.
So again, what you start to see is you start to see an increase in another enzyme, whichis called NNMT, which is a methylated enzyme.
which becomes over expressed as the cell is struggling to actually get rid of this excessnicotinamide.
(20:20):
And this is a problem because it can cause methyl donor depletion because your methylgroups should not be getting used for this process.
They should be getting used for much more important things like DNA repair, et cetera, etcetera.
But they start getting used for this process.
And this becomes even more of a problem if you are taking huge amounts of precursors,because suddenly you're getting piles and piles of these precursors in the cell that the
(20:49):
cell simply can't deal with.
And we do see in some of the human clinical studies that have been done on things like NRand NMN that we see an increase.
in methyl nicotinamide.
So basically as they increase the dose of the precursor, it increases NAD to a certainpoint, but then it doesn't matter how much they increase the precursor, the level of NAD
(21:13):
plateaus.
And that is because the cell can't keep converting it into NAD.
And then what you see is the levels of this methyl nicotinamide, this excretory productkeeps going up and up and up and up.
which again shows us in clear solid evidence, this is not a theory, this is in a humanclinical trial, that the system is becoming overwhelmed and it's starting to have to
(21:37):
change other elements of its physiology to deal with this problem to maintain homeostasis.
So, you know, that is a key, a key part of why we wanted to design something different.
You mentioned very briefly m NAD IVs and also probably NAD injections that have becomevery popular.
(21:57):
mean, a lot of issues around not only the theory behind this, but now some of the clinicalevidence coming out.
Because a lot of people kind of think, well, you know, if NAD is declined, can we give thebody pure NAD and will it just go into the cell and get to where it's needed?
But what an NAD IV or an injection does is it actually puts NAD into our blood.
(22:21):
And NAD is not naturally found at high levels in the blood.
NAD needs to be inside of the cells because that is where all of the pathways that itinteracts with are found.
So what we see and what I've spoke about for a long time now is the fact that yes, an NADIV will get NAD into the body.
but it's not putting it into the right place.
(22:43):
It's putting it into the blood.
And because NAD is a very large and charged molecule, it does not easily diffuse into our
cells.
It struggles to cross the cell membrane and it certainly needs a very special transport, aprotein or carrier to get it in.
And the majority of our cells simply don't have this pathway to get it in.
(23:04):
So what we see is that the NAD is going into a person's blood and it's effectively gettingstuck there.
Now there have been two clinical trials, which I always find astounding that there arestill only two clinical trials looking at what happens to the NAD considering the amount
of clinics that are actually doing NAD IVs.
And one of the clinical studies showed that the NAD is rapidly degraded into precursors.
(23:30):
And then some of these precursors are then taken up.
in which case you've got exactly the same problem as just taking an oral precursor.
The other paper, more alarmingly, actually showed that not only did IV NAD not increaseintracellular NAD, but it triggered an inflammatory reaction.
(23:51):
So they saw increased levels of IL in the leukins in the bodies.
And again, this is worrying because obviously, like we...
We don't want to take NAD to increase inflammation.
But again, you know, looking at this from a purely physiological theoretical point, NAD isnot found in huge levels in the blood.
(24:13):
So if you're suddenly putting a huge dose of NAD into the blood, that's usually only foundinside the cells, the body's thinking, my goodness, what's happened?
Has there been a trauma?
You know, has there been something that's caused the cells to release a lot of theircontents?
and it perceives it as a trauma or a threat.
(24:33):
So it initiates an inflammatory reaction to deal with this perceived trauma.
So again, I'm really happy to see these studies now coming out because it supportssomething that I've kind of been saying theoretically for a long time.
Yeah, it's really interesting.
We've never been huge fans of IV NAD.
I know there are some particular indications where it seems to be useful, like an acutealcohol withdrawal or opioid withdrawal or situations like that.
(25:01):
It can actually be have a very salutary effect.
And yet I think for the kinds of reasons that people are running into a clinic to get anIV of NAD, I think it's actually counterproductive.
um Even though it's well intended, it's counterproductive, right?
That's why I think understanding the biochemistry the way that you do and basicallyarchitecting a system to elevate intracellular NAD levels, the way that you've architected
(25:27):
it becomes really kind of the most intelligent approach.
I will say that in our practice, one of the things that we have also found to be helpfulis
Um, using an ozone sauna to oxidize NADH back to NAD to change the NAD to NADH ratio in afavorable way.
(25:52):
And what we've found is that when you, uh, take something like Neucheto time, um, and you,you load this into your system and then you jump in an ozone sauna.
Oh my gosh.
So like the next three or four days, you can feel like Superman or Wonder Woman, right?
mean, it's just, you really get an amazing boost in NAD.
(26:15):
You can feel the ATP that comes off the mitochondria from it.
if you throw in some, either some D ribose along with some vitamin B2, some riboflavin, Imean, the next thing you know, it's like, my gosh, let's go climb Mount Everest.
So it's been cool.
what?
never heard that combination before, so that's really interesting.
(26:36):
But again, from a scientific standpoint, it makes total sense because we know that NAD isa redox molecule.
And so therefore it naturally flips between two states.
One of them, it's oxidized form, which you see written as NAD plus, and the other it'sreduced form NADH.
And what we know is that as you get older,
(26:58):
the ratio starts to shift more towards NADH and that's not the direction you want it to begoing in.
You want to have a higher ratio of NAD+.
So that's really interesting to use that in combination with the ozone therapy.
Yeah, it seems to work really well.
And we'll take some molecular hydrogen too, actually, just to help kind of mop up, if youwill, some of the uh oxidative stress, the excess oxidative stress you might get from the
(27:27):
ozone.
So anyway, it's something we've kind of biohacked our way into just looking at, you know,what can we do to optimize this, since that's the question we're always asking.
And that seems to be quite honestly, the hot ticket.
In fact, I'm going to no, no pun intended.
think I'm going to do that after this podcast, just cause I got in late last night from aflight that was delayed and I'm feeling like I could use a boost.
(27:51):
So yeah.
Yeah, that sounds like the perfect boost.
And we know things like travel, any jet lag, anything like that is also something thatdepletes NAD, probably because what we haven't...
discussed is, you know, not only does NAD naturally decline with age, but lifestyle isalso a huge thing that impacts our NAD levels, meaning that in some people it will decline
(28:16):
quicker than others.
We know people that travel a lot, people that have circadian disruption, and we seedepleted NAD levels in those people.
So yeah, definitely jump in that, eh in that chamber later and yeah, get those levels backup.
Yeah, very cool.
So, you know, one of the exciting things that I recently discovered on a call that we hadwas the fact that you've been able to kind of refine your packaging, if you will.
(28:46):
In other words, it used to be that the daily dose was about six capsules and now I thinkit's down to three.
Do you want to talk about how you did that without compromising the delivery of theproduct?
I think people would be interested.
when we first developed the product, our aim was to get a product out to market thatactually works and has good science behind it.
(29:07):
my PhD back in the day was actually all surrounding bioavailability of active molecules,of drugs, of nutrients.
So I was always very particular.
and very picky about what formats of different ingredients that we used.
So for example, we've spoken a lot about how we uh target CD38.
(29:31):
Now, the way we target CD38 is through an active ingredient called Apigenin.
We know that Apigenin is a very powerful inhibitor of CD38.
And so we wanted to include this in our product to actually m inhibit it.
And unfortunately, there's a lot of hype about using purified active molecules.
(29:53):
So for example, a lot of the studies on apigenin have used pure apigenin.
They've put it in cell culture.
They've shown that it inhibits CD38, which is great.
But the reality is that in nature, apigenin doesn't exist in a pure form, which means thatyou cannot just take pure apigenin orally, and it will not have the same effect because it
(30:14):
can get damaged in the gut.
So in order to get these active ingredients into the body in stabilized form, often whatyou have to do is use m plant extracts.
So in our formulation, you'll see we use m parsley extract.
And everyone's always like, why on earth?
What is parsley doing in this product?
But we know parsley is a very good source of natural epigenetin.
(30:36):
But that means that you have to use quite a lot of the active ingredients to then actuallybe able to get the effect.
So the result was that when we did our initial clinical trials, the formulation wasn't incapsules.
It was something that you just have as a powder and drink it and it had its effect, but ittasted horrendous.
(30:57):
So that was never going to be acceptable to consumers.
So it had to be encapsulated.
And when it was encapsulated, that's when we realized it's six capsules.
So because we just wanted to get a product out there that worked,
we were much more concerned about having the correct doses and having more capsules thantrying to cut it and have less capsules and, you know, and get it out there.
(31:21):
So that's why when we initially launched, it was six capsules.
But since then, and because we actually launched back in 2019, believe it or not,ingredient science is really advanced.
So some of the ingredients that we use have now become much more purified and extracted.
meaning that we can now use lesser amounts of the raw materials to get the same amount ofactive.
(31:46):
So a key difference, just again as an example of something we've changed, is the alphalipoic acid.
So alpha lipoic acid is a key part of the formulation.
It's one of the ingredients that helps to switch on the NAMPT enzyme, this salvage pathwayenzyme.
Um, but a key problem that we always had was the bulk of this raw material that had to beused to actually get the desired efficacy, in the cells.
(32:14):
And that's because alkaloid proic acid is an incredibly unstable molecule.
So you need to use way over, and to ensure that by the time it's degraded in the body, gotthrough the gut, that there's enough left to have its active, its active role.
Now, when we launched, we used the best product or the best
format that was available but since over the years there have actually become new versionsavailable.
(32:38):
So for example the ALA is now available as an ALA salt and this actually massivelystabilizes the alpha lipoic acid meaning that you can use a huge amount less to actually
get the same active benefit in the body.
So through various tweaks like this, we've been able to actually get the formulation downinto three capsules, which has been a big advantage em for consumers taking it.
(33:06):
You can take all three capsules in one go with food.
And again, because we are very scientifically credible and we want to back everything thatwe're doing, we actually went and did another full clinical trial to prove that it works
just as well.
as the six capsule.
So we did a head-to-head clinical trial to actually show that it still has the samebenefit as well.
(33:29):
Because what we haven't mentioned is we have done a double-blind placebo controlledclinical study on the product, which certainly for supplements is pretty rare.
And also in the NAD space is pretty rare because there's a lot of products out there thatmake a lot of claims, but don't actually have any research in humans to back it up.
Yeah, no, it's really great.
(33:51):
It's nice to see how you continue to kind of think through the product and find ways tooptimize it, not only for efficacy, but also just the convenience of taking fewer
capsules, right?
I mean, there is such a thing as capsule fatigue of people who are taking a lot ofdifferent supplements.
So that's super helpful.
Yeah.
goal with Nishido has always been how do we get this science out to people and make it asuser friendly as possible, whether that's user friendly in terms of the education and
(34:21):
people's understanding of it, or it's user friendly in terms of the price and cost and,you know, acceptability of people actually being able to take it.
Because, you know, as well as I, that these things can actually have a real significantimpact on people's life.
and when they improve their cellular health on the inside, it really does have an impact.
(34:42):
Tell me about the name Neuchito.
Where did that come from?
It sounds like it rhymes with Dorito, but it's...
So, so, no, it's, it's, it's a made up word, but it does have some basis to it in thelongevity field.
because you, will have, you will know of the blue zones.
So the places in the world where, you know, people seem to live to a great age and inrelatively good health compared to a lot of countries in the world.
(35:08):
And one of the famous blue zones is Okinawa in Japan.
and they have a saying, which is Nishi Kusui, which is food.
is path to long life.
So we sort of stole the Nushi bit and put the dough on his way.
So it loosely kind of has a meaning, but also it's very much made up because it's veryhard to get a name that you can trademark.
(35:28):
Right.
That's true.
That's true.
It's hard to get a name you can trademark.
Cool.
All right.
Well, that's good.
I didn't realize it was connected to Okinawa.
So good to know.
All right.
Cool.
sense behind it a little bit anyway.
So what's on the drawing board for you guys?
Anything, any other things you've got up your sleeve there in terms that you're working onor perfecting this?
(35:49):
I mean, in terms of this product, we are always trying to do further clinical research onit.
And a lot of this is based on customer feedback.
So more and more, we get all sorts of customer feedback and some things begin to trendwhere we're hearing it time and time again.
And as a scientific company, we don't like to rely on anecdotal data or, know, customerreviews or quotes.
(36:15):
We like to get some solid evidence behind it.
So we continue to do smaller studies looking at some of this feedback that we're getting.
So like a key one that we've done was a sleep study because we were getting so manycustomers saying that they were noticing an improvement to their sleep quality.
A lot of our customers have the aura rings or the Woot bands.
(36:35):
They were noticing improved deep sleep.
They were noticing better HRV.
So we wanted to do a study to actually measure this.
So we did do a three-month sleep study.
Now granted it was a questionnaire-based study, it was using something called thePittsburgh Sleep Quality Analysis, but we did see in all of the 30 participants that 26 of
(36:56):
them all saw a significant improvement in sleep quality and the four that didn't just sawnothing change.
So that kind of confirms that something is going on here to improve sleep.
Again, theoretically, it makes perfect sense.
NAD is very important in regulating circadian rhythm.
And so we know that it does have a role in sleep.
(37:17):
And so from this, we then want to go on and do a further sleep study, which is then usingtracking devices to actually really measure this.
And the other thing we're really interested in is studies surrounding
What happens if you improve cellular health on the inside?
Does it have visible and noticeable changes to things like skin quality on the outside?
(37:37):
And we've done some studies, again, looking at skin quality with m special skin analyzercameras that take pictures of different layers of the skin.
They take pictures of the pigmentation, rosacea, redness.
And we've saw improvements to these parameters as well.
And the other area that we're really interested in is menopause, because a huge number ofthe positive feedback from customers that we get is actually perimenopausal and menopausal
(38:03):
women that say how much of a real difference it's made to their brain fog and also energylevels.
So we're looking to actually set up a study with specifically with this category ofpeople.
and to get some data behind that.
So that's kind of where we're focused on this product.
But in the, you know, in the backend, again, we're actively researching company.
(38:28):
I have PhD students that collaborate with universities.
We do a lot of research and a big area of interest for us is senescence.
And that's got some really exciting projects that's ongoing and that I can't say too muchabout now, but.
It's kind of all taken away in the background.
And as you know, Senescence and NAD also has a very powerful link between them.
(38:52):
That's right.
No, that's exciting.
That's very cool.
I had not heard about brain fog for perimenopausal women or postmenopausal.
know, men go through andropause also.
I wonder if it would be helpful to them as well.
It might.
we do have men, you know, that report, especially in that sort of period of life, asignificant improvement, especially in things like brain fog, because men do get that as
(39:15):
well.
It's usually a bit more gradual onset as opposed to women that really notice it becauseit's usually quite drastic.
And also, if you look at the hormones in women, things like estrogen are, when they drop,they're incredibly...
pro-inflammatory because estrogen normally keeps inflammation at bay.
So when estrogen suddenly plummets, you get an increase in inflammation and then you getit is right at the time when NAD is massively declining as well.
(39:41):
So you almost get this perfect storm.
So even if you're not addressing the hormones and you're only addressing NAD, you do see asignificant improvement.
Nice.
Yeah, no, that's really cool.
So with the sleep, are you finding that people are taking their Nuchido time at bedtime toget the best results with sleep or just when they take it?
to take it in the morning or as close to the early in the day as you can take it with yourfirst meal of the day.
(40:07):
And that's just because, um, any of the actually naturally fluctuates throughout the day.
It's not a constant.
Um, and it's these fluctuating levels of NAD that actually helped to regulate switchingthis circadian cycle on and off.
Um, and it's better to, it's kind it's not the time at which you take it.
It's just the fact that your whole NAD cycle.
(40:27):
m is functioning better.
So it has that influence over the circadian rhythm as opposed to when the whole NAD cycleis all disrupted, it doesn't have that strong influence as it should to switching on and
off those circadian transcription factors.
Yeah, nice.
Awesome.
Well, lovely to catch up with you again.
(40:48):
Really nice progress that you've made.
And really congratulations on being able to condense the formulation to three capsules.
We just got a hold of some of those in the office here, I don't know, a few weeks ago.
And people are enjoying having to take fewer capsules.
That's been great.
So.
no, I bet.
No, thanks.
been really nice to catch up as well.
It's always good to have a really detailed science chat with someone I appreciate.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Cardiac Cowboys
The heart was always off-limits to surgeons. Cutting into it spelled instant death for the patient. That is, until a ragtag group of doctors scattered across the Midwest and Texas decided to throw out the rule book. Working in makeshift laboratories and home garages, using medical devices made from scavenged machine parts and beer tubes, these men and women invented the field of open heart surgery. Odds are, someone you know is alive because of them. So why has history left them behind? Presented by Chris Pine, CARDIAC COWBOYS tells the gripping true story behind the birth of heart surgery, and the young, Greatest Generation doctors who made it happen. For years, they competed and feuded, racing to be the first, the best, and the most prolific. Some appeared on the cover of Time Magazine, operated on kings and advised presidents. Others ended up disgraced, penniless, and convicted of felonies. Together, they ignited a revolution in medicine, and changed the world.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.